Carotid Endarterectomy vs. Stent: Which Is Right for You?

For most people with significant carotid artery narrowing, both carotid endarterectomy (CEA) and carotid artery stenting (CAS) prevent stroke about equally well over the long term. The landmark CREST trial followed over 2,500 patients for a decade and found no meaningful difference in stroke or death rates between the two procedures.¹ But “equally effective on average” hides real differences in who does best with which procedure. Your age, your anatomy, how recently you had symptoms, and your cardiac history all push the needle one way or the other.

Why Carotid Arteries Need Treatment in the First Place

Atherosclerotic plaque in the carotid arteries is responsible for roughly 10 to 20 percent of all ischemic strokes.² Most of these strokes happen not because the artery is so narrow that blood can’t get through, but because the plaque itself is unstable. Inflammatory cells weaken the plaque’s surface, and when it ruptures, debris or clot material travels into the brain. Histology studies comparing plaques from patients who had symptoms with those who hadn’t show that symptomatic plaques have much higher rates of surface ulceration and rupture, along with thinning of the protective cap that covers the plaque.³ Both CEA and CAS aim to solve this problem, but they go about it very differently.

How Each Procedure Works

Carotid endarterectomy is open surgery. A surgeon makes an incision along the side of the neck, clamps the carotid artery, opens it, and physically removes the plaque from inside the vessel wall. The artery is then repaired, often with a patch sewn over the opening. Studies have shown that using a patch rather than simply stitching the artery closed reduces the risk of later stroke and restenosis.⁴ The procedure typically requires general or regional anesthesia and a neck incision.

Carotid artery stenting is minimally invasive. A catheter is threaded from an artery in the groin (or, in a newer approach, directly through the neck) up to the narrowed carotid. A balloon expands the narrowed segment and a metal mesh stent is left in place to hold the artery open. The plaque stays where it is; it gets compressed against the artery wall. One real concern with stenting is that manipulating wires and catheters through diseased arteries can knock loose tiny bits of debris. Transcranial Doppler studies show that some degree of distal embolization occurs during virtually every stenting procedure.⁵ To counter this, embolic protection devices, essentially tiny filters or balloon systems, are deployed to catch debris before it reaches the brain.

What the Major Trials Found

The CREST trial is the most influential head-to-head comparison. It enrolled 2,502 patients with both symptomatic and asymptomatic carotid stenosis and randomly assigned them to stenting or surgery. At a median follow-up of two and a half years, the combined rate of stroke, heart attack, or death did not differ meaningfully between groups: about 7.2% in the stenting group versus 6.8% in the surgery group.⁶ When the same patients were followed for a full decade, the results held: no significant difference in the primary composite outcome or in the rate of stroke on the treated side.¹

The International Carotid Stenting Study (ICSS), which focused specifically on symptomatic patients, reached a similar long-term conclusion for the most serious strokes: the five-year risk of fatal or disabling stroke was essentially identical between stenting and surgery. However, ICSS did find more non-disabling strokes after stenting, and that difference was concentrated around the time of the procedure itself rather than during the years afterward.⁷ Neither trial found a significant difference in long-term restenosis or vessel occlusion between the two approaches.

The Stroke-Versus-Heart-Attack Tradeoff

The overall similarity between CEA and CAS masks a notable split in the types of complications each one favors. Surgery carries a higher risk of heart attack around the time of the procedure, while stenting carries a slightly higher risk of periprocedural stroke. In CREST, heart attacks occurred about half as often after stenting as after surgery.⁸ A broader meta-analysis confirmed that the 30-day heart attack risk is low after both procedures (under 1%), though several patient-specific factors, such as a history of coronary artery disease or peripheral artery disease, push the risk higher after surgery.⁹

This tradeoff matters in practice. If you already have significant heart disease or have had prior heart attacks, the cardiac stress of open neck surgery under general anesthesia may tip the balance toward stenting. On the other hand, if your primary concern is minimizing any stroke risk around the procedure, surgery has a slight edge on that front. Clinical trials have found that surgical patients are also more likely to experience cranial nerve palsy and neck-site bleeding, while stenting patients face issues like bradycardia and low blood pressure during the procedure. A Lancet Neurology review summarized this neatly: stenting carries a higher risk of non-disabling stroke, while surgery carries a higher risk of heart attack, cranial nerve injury, and access-site bleeding.¹⁰

Age Is the Strongest Predictor

If there is one factor that most strongly determines which procedure performs better, it is your age. In CREST, age acted as what researchers call a treatment-effect modifier: stenting and surgery performed about equally around age 70, but as patients got older, stenting outcomes got progressively worse while surgery outcomes stayed stable. For every additional 10 years of age, the risk of the primary outcome after stenting roughly doubled, while no similar increase appeared after surgery.¹¹

A pooled analysis of four major randomized trials confirmed this pattern and sharpened the numbers. For patients aged 70 to 74 and older, the periprocedural risk of stroke or death after stenting was roughly double that after surgery. Crucially, the excess risk came almost entirely from more strokes during the stenting procedure itself, not from differences in how patients fared in the years afterward.¹² Why older arteries tolerate stenting less well is not entirely settled, but greater vessel tortuosity, heavier calcification, and more complex plaque architecture all make catheter navigation harder and debris embolization more likely. For younger patients, stenting tends to do at least as well as surgery, with the added benefit of avoiding a neck incision.

Sex Differences in Outcomes

Sex also appears to influence how you fare with each procedure, though the evidence is less definitive than for age. A CREST subgroup analysis found that women assigned to stenting had roughly two and a half times the periprocedural stroke rate of women assigned to surgery, while men showed no meaningful difference between the two.¹³ A large database study also found worse outcomes for symptomatic women undergoing stenting compared with surgery, including higher mortality and combined stroke-and-death rates.¹⁴ The reasons are still debated. Smaller artery size and differences in plaque composition have both been proposed, but there is no consensus. In practice, many clinicians factor sex into the discussion, particularly when a woman already has other risk factors that favor surgery.

Neck Surgery Comes with Its Own Risks

One complication unique to endarterectomy is cranial nerve injury. Several nerves run through the surgical field in the neck, and they can be stretched or damaged during the operation. A meta-analysis found that the vagus nerve and the hypoglossal nerve are each injured in about 4% of cases. The reassuring part: fewer than one in seven of those injuries are permanent. Permanent vagus nerve damage occurred in well under 1% of surgeries, and permanent hypoglossal injury was rarer still.¹⁵ In the ICSS trial, about 5.5% of surgical patients developed cranial nerve palsy, and roughly 3.4% developed a significant neck hematoma; the two complications overlapped more than expected by chance.¹⁶ Symptoms of cranial nerve palsy can include hoarseness, difficulty swallowing, or tongue weakness. Most resolve over weeks to months, but they are a real consideration for anyone weighing the two options.

Stenting has a different local complication: bradycardia and hypotension caused by balloon inflation at the carotid bulb, where pressure-sensing nerve endings sit. In one study, about a third of stenting patients experienced significant slowing of the heart rate or a drop in blood pressure during the procedure.¹⁷ This is usually managed with medication during the procedure and rarely causes lasting problems, but it matters if you have underlying cardiac conduction issues.

Transcarotid Artery Revascularization, a Newer Hybrid Approach

A procedure called TCAR has gained traction as a middle ground. Rather than threading a catheter all the way up from the groin through the aortic arch, a surgeon makes a small incision at the base of the neck and accesses the carotid artery directly. Blood flow through the carotid is then temporarily reversed, routing it through an external filter and back to a vein, so that any debris dislodged during stent placement flows away from the brain rather than toward it.¹⁸

A registry-based comparison of all three approaches found perioperative stroke-or-death rates of 2.0% for TCAR, 1.7% for CEA, and 3.7% for traditional stenting from the groin. Surgery performed slightly better than TCAR in the immediate perioperative period, but by one year the difference was no longer statistically significant. TCAR clearly outperformed traditional stenting at both time points.¹⁹ TCAR is particularly appealing for patients who are poor candidates for either open surgery (because of cardiac risk or a hostile neck) or traditional stenting (because of a tortuous aortic arch), though long-term data beyond a few years remain limited.

Anatomy That Tips the Decision

Certain anatomical features make one procedure more attractive than the other, independent of age or cardiac risk. Prior neck radiation is a good example. Radiation can scar tissues around the carotid artery, making open surgery technically challenging and prone to wound healing problems. That has historically pushed irradiated patients toward stenting. However, radiation also distorts the carotid artery itself. In one study, patients with a history of neck radiation had more than double the carotid tortuosity of non-irradiated patients, which complicates filter and stent deployment.²⁰ In this population, TCAR may thread the needle by avoiding both the scarred surgical field and the arch-navigation difficulties of traditional stenting.

Other anatomical considerations include a very high carotid bifurcation (hard to reach surgically), a severely diseased aortic arch (risky for catheter-based approaches from the groin), and prior surgery on the same side (scar tissue complicates repeat endarterectomy). These are among the factors vascular specialists weigh during procedural planning, and they are a major reason the decision is almost never one-size-fits-all.

What About Just Taking Medication?

Modern medical therapy, meaning aggressive blood pressure control, high-intensity statins, and antiplatelet drugs, has improved so much that it is now a serious standalone option for certain patients. An interim analysis of the ECST-2 trial found no evidence that adding revascularization to optimized medical therapy provided a benefit in the first two years for patients whose predicted stroke risk was low or intermediate.²¹ Five-year data from a separate prospective study of asymptomatic patients treated with best medical therapy alone showed a cumulative stroke or TIA rate on the treated side of about 6%, translating to roughly 1.3% per year.²²

A commentary on the recent CREST-2 findings noted that in that trial, surgery did not reduce the four-year composite outcome compared with medical therapy alone, because the early procedural risk offset later stroke-prevention gains. Stenting, on the other hand, did show a statistically significant benefit over medical therapy alone despite small procedural risks.²³ These results are still being debated and longer follow-up will clarify the picture, but they underscore that medication alone is a legitimate choice, particularly if you have asymptomatic disease and a low predicted stroke risk. The question is increasingly not “stent or surgery?” but “do I need a procedure at all?”

Recovery and Hospital Stay

If you do proceed with a procedure, practical differences in recovery are worth knowing. A systematic review and meta-analysis found that endarterectomy took substantially longer in the operating room (averaging about 192 minutes versus roughly 78 minutes for stenting) and involved a longer hospital stay (about 3.1 days versus 2.6 days).²⁴ A propensity-matched analysis of hospital data found that the difference in length of stay was most pronounced for asymptomatic patients, where stenting patients went home significantly earlier. Among symptomatic patients, the gap was smaller.²⁵

After endarterectomy, you’ll have a neck incision that needs to heal, and some soreness, bruising, or numbness around the surgical site is normal. After stenting, the groin puncture site (or small neck incision for TCAR) heals more quickly, and most people feel physically recovered sooner. Either way, you’ll need ongoing follow-up imaging, typically with ultrasound, to check for restenosis.

Blood Thinners and Medication After the Procedure

The medication regimens after each procedure differ, and this can influence the choice for patients at high bleeding risk. After stenting, you’ll need dual antiplatelet therapy (typically aspirin plus a second antiplatelet drug like clopidogrel) for at least several weeks to prevent clot formation on the new stent. After endarterectomy, aspirin alone is often sufficient. One study found that using dual antiplatelet therapy around the time of endarterectomy slightly decreased in-hospital stroke risk but came with a 60% increase in bleeding complications compared with aspirin alone.²⁶

For patients who also have atrial fibrillation and need blood thinners, the medication picture gets more complicated after stenting. Combining an anticoagulant with two antiplatelet drugs (so-called triple therapy) led to bleeding events in nearly a quarter of patients in one study, compared with 4% in those on dual antiplatelets alone. A regimen of a direct oral anticoagulant plus a single antiplatelet drug appeared to offer a better safety profile while maintaining protection against clot-related events.²⁷ If you take blood thinners for atrial fibrillation, your doctors will need to carefully calibrate the post-procedure regimen regardless of which procedure you choose.

Timing also matters for stenting. A conference abstract analyzing patients treated very soon after a stroke-like event (within seven days) found that the higher periprocedural risk with stenting in that window might partly reflect inadequate antiplatelet loading. Patients who received only a bolus dose of clopidogrel without two days of maintenance dosing had significantly higher event rates, while those who had adequate antiplatelet preparation fared similarly to surgical patients.²⁸ This suggests that the disadvantage of early stenting may be partly correctable with faster-acting antiplatelet drugs.

Silent Brain Lesions After Treatment

Even when both procedures go smoothly and the patient has no obvious neurological symptoms, brain imaging can reveal tiny new lesions afterward. These show up as bright spots on a type of MRI called diffusion-weighted imaging and represent small areas of restricted blood flow in the brain. A recent study found that these silent lesions occurred more often after stenting than after surgery.²⁹ The clinical significance of these microlesions is still being worked out. Most do not cause detectable symptoms at the time, but there is ongoing debate about whether they contribute to subtle cognitive decline over years. This is an area of active research and one reason some specialists lean toward surgery in younger patients who have decades of brain health ahead of them.

How Cost Plays Into the Decision

From a health-system perspective, the two procedures come out fairly close in cost, though the details depend on where you live and how costs are structured. A simulation-based cost-effectiveness analysis found that both revascularization strategies were actually cost-saving compared with modern medical management alone, largely because preventing a stroke avoids the enormous expense of post-stroke care.³⁰ An analysis from a different national health system found that surgery was slightly less expensive per patient than stenting and produced marginally better outcomes, making it the dominant strategy from a pure cost-effectiveness standpoint.³¹ In practice, cost rarely drives the decision between CEA and CAS at the individual patient level, but it can influence hospital and insurance preferences, particularly for asymptomatic disease where the benefit of any procedure over medication alone is marginal.

Putting It Together in Practice

No single factor settles the decision. What actually happens in a good clinical consultation is a weighing of several variables simultaneously. Age over 70 strongly favors surgery. Significant cardiac disease or a history of neck radiation favors stenting or TCAR. Being a woman may nudge the decision toward surgery, though the evidence is less airtight. Tortuous aortic arch anatomy makes traditional groin-based stenting harder and may favor TCAR or surgery. If you are asymptomatic and your risk profile is low, the strongest emerging option may be optimized medication with no procedure at all, with periodic ultrasound monitoring.

The field is evolving fast. TCAR barely existed a decade ago and is now performed thousands of times a year. Trials like ECST-2 and CREST-2 are reshaping when any procedure is recommended at all. Embolic protection devices keep improving. Faster-acting antiplatelet drugs may close some of the periprocedural gap between stenting and surgery. If you are facing this decision today, the most useful step is not to walk in with a firm preference for one procedure but to have a detailed conversation with a vascular specialist about your specific anatomy, your symptoms, your heart, and your tolerance for different types of risk.